RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Mohammad Tabatabai to Buprenorphine

Back to Details
This is a "connection" page, showing publications Mohammad Tabatabai has written about Buprenorphine.
Mohammad Tabatabai
Connection Strength
0.944
Buprenorphine
  1. Cooper RL, Edgerton RD, Watson J, Conley N, Agee WA, Wilus DM, MacMaster SA, Bell L, Patel P, Godbole A, Bass-Thomas C, Ramesh A, Tabatabai M. Meta-analysis of primary care delivered buprenorphine treatment retention outcomes. Am J Drug Alcohol Abuse. 2023 11 02; 49(6):756-765.
    View in: PubMed
    Score: 0.944
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support